Dyne Therapeutics Information
Contact top employees from
Dyne Therapeutics
Summary
Dyne Therapeutics is a public company that has been in the industry for 9 years. The company currently specializes in the Biotechnology, Biotechnology, Pharmaceuticals areas. The position of the President & CEO is occupied by Joshua Brumm. Its headquarters is located at Waltham, Massachusetts, USA. The number of employees ranges from 25 to 100. The Dyne Therapeutics annual revenue is estimated at < 1M. Total funding of the company - $433M. To connect with Dyne Therapeutics employee register on SignalHire.
Organization Website | dyne-tx.com |
Social Links |    |
Phone Number | 857-201-2767 |
Industries | |
Headquarters Location | 1560 Trapelo Rd, Waltham, Massachusetts, 02451 US |
Employees Size | 100-200 employees |
SIC Code | 2836, 2834 |
DMA Code | Greater Boston |
Founded | 2018 |
Operating Status | Independent Company |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2017 | Privately Held | 250 - 500 | 31M | $65.8M | |
| 2013 | Privately Held | 25 - 100 | 9.2M | $390.3M | |
| 2006 | Public Company | 1 - 25 | 16M | $153.7M | |
| 2016 | Public Company | 25 - 100 | 10M | $178M |
Estimated Website Traffic
The chart shows a growth in traffic to the dyne-tx.com website. In November, traffic increased to 15988, compared to 15354 in the previous month. The highest traffic in 2025 was recorded in July, reaching 18946 visits.
Employees Turnover 4 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Length of Employment
Employee tenure at Dyne Therapeutics shows a diverse range of experience levels:
7% have been with the company for less than 1 year27% for 1–2 years30% for 3–4 years30% for 5–7 years3% for 8–10 years3% have over 11 years of service at Dyne TherapeuticsEx-employees positions
In Company
In New Company
Contact top employees from
Dyne Therapeutics
Mary Geissler
Vice President, Global Regulatory Affairs
Stefano Zanotti
Senior Vice President, Head of Neuromuscular Research
Timothy Weeden
Vice President - Head of Platform Development
Kelly Comma
Executive Assistant to Chief Innovation Officer & Chief Scientific Officer
James Toler
Director Preclinical Outsourcing
Joan Roubian Apanian
Senior Manager, Accounting
Sarah Farina
Associate Director of Quality Operations
Melissa Rae Good
Associate Director
Jason Berlin
Senior Director Clinical Operations
Jay Brahmbhatt
Senior Director, Regulatory Operations - Submissions & Information Management
Frederick Jao
Clinical Trial Associate
Cortney Miller
Associate Director Clinical Operations Study Lead
Kristin Glab
Director, Drug Safety & PV Scientist
Prashant Bansal
Executive Director, Digital Health Technologies and Imaging Biomarkers
Anita Torossian
Central Nervous System Co-op
Marco Fontana
Associate Director, Procurement
Stephen McCalley
Associate Director, Medical Science Liaison
Marcel Meth
Independent Consultant at Dyne Therapeutics (Collaboration, AI, Teams, SharePoint, Exchange, Office)
Jennifer Ragucci
Executive Assistant
Nicholas Yoder
Executive Director
Vicki Brownville
Document Control Consultant
Amanda Lewis
Director Oligonucleotide CMC and External Manufacturing
Scott Radogna
Senior Research Associate
Lilian Griggs
Senior Accountant
Yashvi Gandhi
Co-op, Pipeline Expansion, Neuromuscular Research
Varshini Rakesh Kumar
Platform Analytics CO-OP
Ji Yoon Kim
Scientist
Matteo Guerciolini
Intern
Similar Companies
FAQ
Dyne Therapeutics operates in the Biotech industries. More details can be found on the official website: dyne-tx.com.
The headquarters of Dyne Therapeutics are located in Waltham, United States.
The current CEO of Dyne Therapeutics is Joshua Brumm
You can contact Dyne Therapeutics by phone at 857-201-2767.
Dyne Therapeutics currently employs 100-200 people.
Dyne Therapeutics's revenue is approximately < 1M.
Well-known competitors of Dyne Therapeutics include Capital Rx, Avidity Biosciences, Inc., Lisata Therapeutics, Inc. and Keros Therapeutics.
